Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Autolus Therapeutics Earlier Reported Q2 EPS $(0.46) Beats $(0.51) Estimate

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 2.13 percent increase over losses of $(0.47) per share from
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 2.13 percent increase over losses of $(0.47) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Charles Schwab

By Benzinga Insights
Today, 6:26 AM
Charles Schwab (NYSE:SCHW) is set to give its latest quarterly earnings report on Monday, 2022-07-18. Here's what investors need to know before the announcement. Analysts estimate that Charles Schwab will report an earnings per share (EPS) of $0.92.

SCHW